Skip to main content

The UNC Department of Urology is proud to echo the recent announcement by the UNC School of Medicine of the appointment of Dr. Angela Smith as the Associate Dean for Faculty Affairs and Leadership Development. In this new role, Dr. Smith will be responsible for leading initiatives aimed at enhancing the professional growth and development of faculty members within the school.

Dr. Smith brings a wealth of experience and expertise to this new role. Her extensive background in the field of urology and her commitment to advancing the field has earned her recognition and accolades within the academic and medical communities.

Most recently, Dr. Smith was promoted to Professor with Tenure, a recognition of her exceptional contributions to the field of urology and her dedication to providing the highest level of care to her patients. Prior to this, she also recently received the prestigious Gold Cystoscope Award from the American Urological Association, an honor given to individuals who have made significant contributions to the field of urology.

Throughout her career, Dr. Smith has been dedicated to mentoring and empowering the next generation of medical professionals. Her passion for education and leadership development, combined with her experience in the field of urology, make her the ideal candidate for this new role.

We are thrilled for Dr. Smith to enter this new role and are confident that she will be key in advancing the school’s efforts to provide faculty members with the support and resources they need to succeed. With her passion and expertise, we are certain that she will help to build a brighter future for our faculty and our students.


More About Dr. Smith

A native of Pittsburgh, Dr. Angela Smith is a quadruple Tar Heel; earning her Bachelor of Arts, Bachelor of Science, Master of Science, and Doctor of Medicine degrees all from UNC-Chapel Hill.

Currently, Dr. Angela Smith is the Director of Urologic Oncology at the UNC Lineberger Comprehensive Cancer Center and primarily treats GU malignancies, including bladder, prostate, and kidney cancer.

Dr. Smith has a background in health services research and biostatistics and has an interest in patient-centered outcomes research, risk stratification, and quality of care for invasive bladder cancer.

Dr. Smith is the co-PI for a PCORI large pragmatic trial in BCG refractory bladder cancer, PI for a PCORI Engagement Award with the Bladder Cancer Advocacy Network to engage patients in the research process, and has been funded by an AHRQ K08 grant that integrates patient-reported outcomes into post-cystectomy care through mobile health technology.

Dr. Smith has also served on the PCORI Advisory Panel for the Assessment of Prevention, Diagnosis, and Treatment Options, representing clinicians. Dr. Smith also serves as the Assistant Secretary of the American Urological Association and has recently served on the AUA Quality Improvement and Patient Safety Committee, Scientific Advisory Board for the Bladder Cancer Advocacy Network, Journal of Urology Editorial Board, and is the current chair of the Urology Care Foundation Bladder Health Committee.